Phase II Trial of S-Fluorouracil and Recombinant Interferon Alfa-2B in Metastatic Carcinoma Colorectal

12. Laven P, Mittelman A, Douglass H, Engstrom P, Klaassen D. Survival and response to chemotherapy for advanced colorectal adenocarcinoma. Cancer 1980,46,1536-1543. 13. Kemeney N, Braun DW. Prognostic factors in advanced colorectal carcinoma. Am3 Med 1983,74,786-794. 14. Edler L, Heim ME, Quintero C, Brummer T, Queisser W. Prognostic factors of advanced colorectal cancer patients. Eur3 Cancer Clin Oncoll986,22,1231-1237. 15. Goslin R, Steele G, Zamcheck N, Mayer R, MacIntyre J. Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon or rectum. Dis Colon Rectum 1982, 25, 749-754. 16. Finan PJ, Marshall RJ, Cooper EH, Giles GR. Factors affecting survival in patients presenting with synchronous hepatic metastases from colorectal cancer: a clinical and computer analysis. BrJ Surg 1985,72,373-377. 17. DeBraun LM, Van De Velde CJH, Bouwhuis-Hoogerwerf ML, Zwaveling A. Diagnostic evaluation and survival analysis of colorectal cancer patients with liver metastases. 3 Surg Oncol 1987, 34, 81-86. 18. Bedikian AY, Chen TT, Malahy M, Patt YZ, Bodey GP. Prognostic factors influencing survival of patients with advanced colorectal cancer: hepatic artery infusion versus systemic intravenous chemotherapy for liver metastases.3 Clin 0x02 1984,2, 174-180. 19. Tartter PI. Pretreatment prognostic factors in colorectal cancer patients with synchronous liver metastases. Eur3 Surg 0~1~011987, 13,485-491. 20. Wood CB, Gillis CR, Blumgart LH. A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncoll976,2,285-288.